Capital Cell
Capital Cell is a Barcelona equity crowdfunding platform for early-stage biotech and medical companies, licensed by Spain's CNMV under the EU crowdfunding regulation and open across 26 other EU states from about EUR 500 a ticket. Its public track record lists 156 rounds since April 2016 (EUR 157.1 million of round size, including lead investors): 138 'In business', 14 'Write-off' and 4 'Exit' at three companies, with exit proceeds not published. Its own analysis of the 2015 to 2022 portfolio put reported value at 3.19x invested capital on paper, 1.14x without its three best investments, and cash returned as of November 2022 at 0.51.

No platform response on record for this profile. Is this your platform? Respond or claim it.
Platform Identity
- Website
- capitalcell.com
- Headquarters
- Barcelona, ES
- Founded
- 2015
- Parent
- PFP CAPITAL CELL, S.L. (NIF B65998288; LEI 9598002AZWLHC7NUHX82), Barcelona; sole director Daniel Oliver Uriel (CNMV). The CNMV register lists 'CAPITAL CELL, LTD' as 100% owner; that UK company (Companies House 10173220) was wound up voluntarily in 2024 and dissolved on June 17, 2025. Current ownership not established.
- Platform type
- EU Equity Crowdfunding Platform (Life Sciences)
- Regulatory
- foreign_regulated
- Eligibility
- retail
AltStreet Coverage
- Review status
- Published
- Coverage type
- Investment platform
- Review date
- Nov 9, 2026
- Last updated
- Nov 10, 2026
- Composite score
- 4.0
Key Data Points
AltStreet has not yet aggregated SEC primary-source or on-chain operational data for this platform. The full review surfaces the structural and qualitative findings from current coverage.
Reference Reading
AltStreet reference pages on the filings and mechanics behind this platform's category.
Claim a Verified Profile.
Verified Profiles give covered platforms a structured channel to respond to AltStreet's editorial framework with source-documented amendments, additional disclosures, and attributed corrections — improving signal quality for buyers and investors evaluating your platform.
